3/10/2022 Assessing the impact of the COVID-19 pandemic on emergency department use for patients undergoing cancer-directed surgeries Eskander A, Li Q, Yu J, Hallet J, Coburn N, Dare A, Chan KKW, Singh S, Parmar A, Earle CC, Lapointe-Shaw L, Krzyzanowska MK, Hanna TP, Finelli A, Louie AV, Look-Hong N, Irish JC, Witterick I, Mahar A, Urbach DR, Enepekides D, Sutradhar R; on behalf of the Pandemic—Ontario Collaborative in Cancer Research (POCCR). Curr Oncol. 2022; 29(3):1877-89. Epub 2022 Mar 10. DOI: https://doi.org/10.3390/curroncol29030153
2/1/2022 Incident cancer detection during the COVID-19 pandemic Eskander A, Li Q, Yu J, Hallet J, Coburn NG, Dare A, Chan KKW, Singh S, Parmar A, Earle CC, Lapointe-Shaw L, Krzyzanowska MK, Hanna TP, Finelli A, Louie AV, Look Hong N, Irish JC, Witterick IJ, Mahar A, Noel CW, Urbach DR, McIsaac DI, Enepekides D, Sutradhar R. J Natl Compr Canc Netw. 2022; 20(3):276-84. Epub 2022 Feb 1. DOI: https://doi.org/10.6004/jnccn.2021.7114
10/16/2020 Medical immunosuppression and outcomes in cutaneous melanoma: a population-based cohort study Bogach J, Wright FC, Austin J, Cheng SY, Diong C, Sutradhar R, Baxter NN, Hong NJ. Ann Surg Oncol. 2020; 28(6):3302-11. Epub 2020 Oct 16. DOI: https://doi.org/10.1245/s10434-020-09224-9